Phosphate Regulation of Vascular Smooth Muscle Cell Calcification

Circulation Research - Tập 87 Số 7 - 2000
Shuichi Jono1, Marc D. McKee1, Charles E. Murry1, Atsushi Shioi1, Yoshiki Nishizawà1, Katsuhito Mori1, Hirotoshi Morii1, Cecilia M. Giachelli1
1From the Departments of Bioengineering (S.J., C.M.G.) and Pathology (C.E.M., C.M.G.), University of Washington, Seattle, Wash; Dentistry (M.D.M) and Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada; and Second Department of Internal Medicine (A.S., Y.N., K.M., H.M.), Osaka City University Medical School, Osaka, Japan.

Tóm tắt

Abstract —Vascular calcification is a common finding in atherosclerosis and a serious problem in diabetic and uremic patients. Because of the correlation of hyperphosphatemia and vascular calcification, the ability of extracellular inorganic phosphate levels to regulate human aortic smooth muscle cell (HSMC) culture mineralization in vitro was examined. HSMCs cultured in media containing normal physiological levels of inorganic phosphate (1.4 mmol/L) did not mineralize. In contrast, HSMCs cultured in media containing phosphate levels comparable to those seen in hyperphosphatemic individuals (>1.4 mmol/L) showed dose-dependent increases in mineral deposition. Mechanistic studies revealed that elevated phosphate treatment of HSMCs also enhanced the expression of the osteoblastic differentiation markers osteocalcin and Cbfa-1. The effects of elevated phosphate on HSMCs were mediated by a sodium-dependent phosphate cotransporter (NPC), as indicated by the ability of the specific NPC inhibitor phosphonoformic acid, to dose dependently inhibit phosphate-induced calcium deposition as well as osteocalcin and Cbfa-1 gene expression. With the use of polymerase chain reaction and Northern blot analyses, the NPC in HSMCs was identified as Pit-1 (Glvr-1), a member of the novel type III NPCs. These data suggest that elevated phosphate may directly stimulate HSMCs to undergo phenotypic changes that predispose to calcification and offer a novel explanation of the phenomenon of vascular calcification under hyperphosphatemic conditions. The full text of this article is available at http://www.circresaha.org.

Từ khóa


Tài liệu tham khảo

Blumenthal HT, Lansing AI, Wheeler PA. Calcification of the media of the human aorta and its relationship to intimal arteriosclerosis, aging and disease. Am J Pathol. 1944;20:665–687.

10.1016/0002-9149(70)90790-3

10.1161/circ.86.1.1617791

10.1016/0735-1097(92)90319-I

10.1016/S0002-9440(10)65313-8

10.1172/JCI117205

10.1161/atvb.15.11.2003

10.1161/res.84.2.166

10.1038/386078a0

10.1038/36285

Spicer SS, Lewis SE, Tashian RE, Schulte BA. Mice carrying a CAR-2 null allele lack carbonic anhydrase II immunohistochemically and show vascular calcification. Am J Pathol. 1989;134:947–954.

10.1006/jmcc.1997.0446

10.1101/gad.12.9.1260

10.5551/jat1994.3.90

10.1007/978-1-4684-7758-0_20

Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis. 2000;35:1236–1237.

Winchester JF, Rotellar C, Goggins M, Robino D, Rakowski TA, Argy WP. Calcium and phosphate balance in dialysis patients. Kidney Int Suppl. 1993;41:S174–S178.

10.1002/jbm.820290212

Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol. 1983;113:143–155.

10.3109/07853899109150522

10.1172/JCI117718

10.1073/pnas.89.4.1224

10.1161/atvb.17.6.1135

10.1007/BF02555151

O’Hara B, Johann SV, Klinger HP, Blair DG, Rubinson H, Dunn KJ, Sass D, Vitek SM, Robins T. Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus. Cell Growth Differ. 1990;1:119–127.

10.1016/0306-3623(95)02017-9

10.1016/S0092-8674(00)80257-3

10.1073/pnas.88.21.9608

10.1016/S0021-9258(17)37417-3

Werner A, Murer H, Kinne RK. Cloning and expression of a renal Na-Pi cotransport system from flounder. Am J Physiol. 1994;267:F311–F317.

Verri T, Markovich D, Perego C, Norbis F, Stange G, Sorribas V, Biber J, Murer H. Cloning of a rabbit renal Na-Pi cotransporter, which is regulated by dietary phosphate. Am J Physiol. 1995;268:F626–F633.

10.1096/fasebj.8.11.8070635

10.1007/BF00386183

10.1038/ki.1996.135

10.1210/endo.138.12.5561

10.1161/atv91.14.10.7918316

10.1172/JCI117501

Sarkozi L, Szabo A. Effect of hemodialysis on the distribution of phosphates in blood. Clin Physiol Biochem. 1994;1989:7:184–188.

10.1053/ajkd.1998.v31.pm9531176

10.1056/NEJM200005183422003

10.1002/jbmr.5650110714

10.1016/0169-6009(91)90100-E

Schor AM, Canfield AE, Sutton AB, Arciniegas E, Allen TD. Pericyte differentiation. Clin Orthop. 1995;313:81–91.

10.1097/00041552-199409000-00005

Giachelli CM, Steitz S, Jono S. Potential roles of bone matrix proteins in vascular calcification. Clin Calcium. 1999;9:20–27.

10.1016/S0092-8674(00)80259-7

10.1016/S0021-9258(18)55196-6

Kim KM. Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc. 1976;35:156–162.